Elevated citrate in pediatric astrocytomas with malignant progression. - Wikidata - wikimedia - TriplyDB

Elevated citrate in pediatric astrocytomas with malignant progression.

Elevated citrate in pediatric astrocytomas with malignant progression.

http://www.wikidata.org/entity/Q35225263

about

In-Vivo Proton Magnetic Resonance Spectroscopy of 2-Hydroxyglutarate in Isocitrate Dehydrogenase-Mutated Gliomas: A Technical Review for Neuroradiologists Functional imaging in adult and paediatric brain tumours.In vivo detection of citrate in brain tumors by 1H magnetic resonance spectroscopy at 3T.Clinical proton MR spectroscopy in central nervous system disorders GC/MS-based metabolomic analysis of cerebrospinal fluid (CSF) from glioma patients.Cerebrospinal fluid metabolomics implicate bioenergetic adaptation as a neural mechanism regulating shifts in cognitive states of HIV-infected patients Metabolite control of angiogenesis: angiogenic effect of citrate.Citrate concentrations increase with hypoperfusion in pediatric diffuse intrinsic pontine glioma.

P2860

Q28069062-51CACD7D-52F7-47E7-B49F-B8D463FE4C9B Q30577397-E562DCA0-FA5A-43FD-BFBC-69A3523338F5 Q30677166-582C53F7-F901-40C2-A19D-0735379D57FC Q30764446-19B8AFB5-2C92-49C9-B282-BEA10611542C Q36798779-293FBA5D-C05E-4DAC-952C-B640DAA8974D Q41528498-EA9FB6CD-26D0-48FA-8C33-30E93884A45F Q43855694-EF298472-A42D-41F1-9BFF-8671A2F3D4A4 Q48334821-F4A370B4-0EDF-4247-A3EC-9F49EAFECC24

P2860

Elevated citrate in pediatric astrocytomas with malignant progression.

http://www.wikidata.org/entity/Q35225263

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Elevated citrate in pediatric astrocytomas with malignant progression.

@ast

Elevated citrate in pediatric astrocytomas with malignant progression.

@en

type

label

Elevated citrate in pediatric astrocytomas with malignant progression.

@ast

Elevated citrate in pediatric astrocytomas with malignant progression.

@en

prefLabel

Elevated citrate in pediatric astrocytomas with malignant progression.

@ast

Elevated citrate in pediatric astrocytomas with malignant progression.

@en

P1433

Q35225263-EFAE56C5-6BDD-4070-99DD-E1E351AA5D39

P1476

Q35225263-EBD79274-EE02-4083-B409-77D89AA2C67F

P2093

Q35225263-0A86D9F7-2DF5-4D32-BC94-1CA8B99AB2A9

Q35225263-7A6EF0BF-BB78-4251-A724-BA9598BCBC91

Q35225263-95AD325A-7E2D-4718-8DA6-D8AEBE0868F0

Q35225263-C5E3683B-985A-4798-851A-04FB4F6A8BD8

Q35225263-CC48C602-CAE4-4912-A4BE-DB115609F0CD

Q35225263-E5DA2F07-FF8F-4D6A-99D0-EC2A6FB29991

Q35225263-FA1F1195-2BE9-424D-8066-5633EBD119E6

Q35225263-FAC2DA8C-C620-48A4-AA14-0AD785CFE781

P2860

Q35225263-007321E7-AFDC-477E-BDE1-F7BC0B6FC38B

Q35225263-0CB05D7D-400A-4F7B-B725-8B8312FFE979

Q35225263-15731313-8192-4881-80C6-05198DB0FB1B

Q35225263-20162D6D-4959-49C2-991A-0B627BCFB435

Q35225263-23FFFDAD-E7C4-4BD6-B423-1F63C9245815

Q35225263-27703461-F6FD-44DF-9EF5-BC908D99830E

Q35225263-2798A96F-519E-473E-8B5F-C94C5ADB59DE

Q35225263-2799377A-4500-4A32-B277-98DFB6B2CD93

Q35225263-28071F61-75F1-4551-B9AE-B02BA1C85704

Q35225263-28C69418-6F29-40E5-9B03-187E3C6A469B

P304

Q35225263-99E11763-7361-46C9-9042-4A47D8FB5E17

P31

Q35225263-FFEBA31C-CAF3-4352-9F8A-F339697C119B

P356

Q35225263-3EC03F47-48EC-491A-93E4-8A725FD1DBF5

P433

Q35225263-58E559A4-2A83-43A4-86C1-84466FE8BA25

P478

Q35225263-4F68202D-0612-4BCD-B85B-7073211DD37E

P577

Q35225263-8C4F7570-47B5-43D1-8700-6E7853460C06

P5875

Q35225263-6A355D0A-4B6D-4CFA-BBB7-C87B604EA5C5

P698

Q35225263-4DF65CC2-5D2B-45A1-BBC2-C0B16BE47069

P932

Q35225263-85564331-CE1E-421B-93CF-90E6531239B3

P356

P1433

P1476

Elevated citrate in pediatric astrocytomas with malignant progression.

@en

P2093

Ashok Panigrahy

http://www.w3.org/2001/XMLSchema#string

Floyd H Gilles

http://www.w3.org/2001/XMLSchema#string

Girish Dhall

http://www.w3.org/2001/XMLSchema#string

Jonathan L Finlay

http://www.w3.org/2001/XMLSchema#string

Mark D Krieger

http://www.w3.org/2001/XMLSchema#string

Marvin D Nelson

http://www.w3.org/2001/XMLSchema#string

Mikhail Laskov

http://www.w3.org/2001/XMLSchema#string

Stefan Blüml

http://www.w3.org/2001/XMLSchema#string

P2860

Understanding the Warburg effect: the metabolic requirements of cell proliferation

An integrated genomic analysis of human glioblastoma multiforme

IDH1 and IDH2 mutations in gliomas

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

On the Origin of Cancer Cells

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects

Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha

Brainstem Gliomas. A 10-year institutional review.

Studies of human tumors by MRS: a review.

P304

1107-1117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOR087

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51504769

http://www.w3.org/2001/XMLSchema#string

P698

21771868

http://www.w3.org/2001/XMLSchema#string

P932

3177657

http://www.w3.org/2001/XMLSchema#string